• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Idenix Pharmaceuticals

Idenix Pharmaceuticals

  1. Merck to take $2.9 billion charge on hepatitis C drug

    Merck to take $2.9 billion charge on hepatitis C drug

©2017 Morningstar Advisor. All right reserved.